
Emerging Modalities and Strategic Innovation in the Biopharma R&D Landscape
The biopharmaceutical R&D landscape has undergone significant transformation in the past decade, as evidenced by unprecedented diversity in the industry’s pipeline composition as well as current therapeutic approaches. In today’s biopharma R&D …